{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:46:34Z","timestamp":1761896794275,"version":"3.37.3"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T00:00:00Z","timestamp":1524528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI113893"],"award-info":[{"award-number":["R01AI113893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0196370","type":"journal-article","created":{"date-parts":[[2018,4,24]],"date-time":"2018-04-24T17:31:42Z","timestamp":1524591102000},"page":"e0196370","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2032-1528","authenticated-orcid":true,"given":"Rachel C.","family":"Doran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen P.","family":"Tatsuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-1592","authenticated-orcid":true,"given":"Phillip W.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,4,24]]},"reference":[{"issue":"14","key":"ref1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"5\u20136","key":"ref2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.vaccine.2003.08.023","article-title":"Safety profile of recombinant canarypox HIV vaccines","volume":"22","author":"G de Bruyn","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"ref3","first-page":"S277","article-title":"Development of bivalent rgp120 vaccines to prevent HIV type 1 infection","volume":"14","author":"PW Berman","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1999.0031","article-title":"Development of bivalent (B\/E) vaccines able to neutralize CCR5-dependent viruses from the United States and Thailand","volume":"265","author":"PW Berman","year":"1999","journal-title":"Virology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/01.qai.0000136091.72955.4b","article-title":"Phase I\/II study of a candidate vaccine designed against the B and E subtypes of HIV-1","volume":"37","author":"P Pitisuttithum","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"21","key":"ref6","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"M Bonsignori","year":"2012","journal-title":"J Virol"},{"issue":"228","key":"ref7","doi-asserted-by":"crossref","first-page":"228ra39","DOI":"10.1126\/scitranslmed.3007730","article-title":"Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination","volume":"6","author":"NL Yates","year":"2014","journal-title":"Sci Transl Med"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"e87572","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection","volume":"9","author":"S Zolla-Pazner","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"e75665","DOI":"10.1371\/journal.pone.0075665","article-title":"Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial","volume":"8","author":"R Gottardo","year":"2013","journal-title":"PLoS One"},{"issue":"7420","key":"ref10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature11519","article-title":"Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2","volume":"490","author":"M Rolland","year":"2012","journal-title":"Nature"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"e55701","DOI":"10.1371\/journal.pone.0055701","article-title":"N332-Directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function","volume":"8","author":"M Pancera","year":"2013","journal-title":"PLoS One"},{"issue":"6059","key":"ref12","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1213256","article-title":"A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan","volume":"334","author":"R Pejchal","year":"2011","journal-title":"Science"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nsmb.2594","article-title":"Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120","volume":"20","author":"L Kong","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"47","key":"ref14","doi-asserted-by":"crossref","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"H Mouquet","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"e1003342","DOI":"10.1371\/journal.ppat.1003342","article-title":"Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans","volume":"9","author":"JP Julien","year":"2013","journal-title":"PLoS Pathog"},{"issue":"14","key":"ref16","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","article-title":"The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120","volume":"76","author":"RW Sanders","year":"2002","journal-title":"J Virol"},{"issue":"236","key":"ref17","doi-asserted-by":"crossref","first-page":"236ra63","DOI":"10.1126\/scitranslmed.3008104","article-title":"Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV","volume":"6","author":"D Sok","year":"2014","journal-title":"Sci Transl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature10373","article-title":"Broad neutralization coverage of HIV by multiple highly potent antibodies","volume":"477","author":"LM Walker","year":"2011","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9998","DOI":"10.1128\/JVI.05045-11","article-title":"Analysis of a clonal lineage of HIV-1 envelope V2\/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors","volume":"85","author":"M Bonsignori","year":"2011","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.1038\/ncomms8479","article-title":"Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies","volume":"6","author":"LK Pritchard","year":"2015","journal-title":"Nat Commun"},{"issue":"31","key":"ref22","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1073\/pnas.1006498107","article-title":"Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens","volume":"107","author":"KJ Doores","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1128\/JVI.00154-11","article-title":"Enzyme digests eliminate nonfunctional Env from HIV-1 particle surfaces, leaving native Env trimers intact and viral infectivity unaffected","volume":"85","author":"ET Crooks","year":"2011","journal-title":"J Virol"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.celrep.2015.05.017","article-title":"Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers","volume":"11","author":"LK Pritchard","year":"2015","journal-title":"Cell Rep"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"e43903","DOI":"10.1371\/journal.pone.0043903","article-title":"Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials","volume":"7","author":"B Yu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref26","first-page":"155","article-title":"Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo","volume":"243","author":"AG Morell","year":"1968","journal-title":"J Biol Chem"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0021-9258(19)76994-4","article-title":"The role of sialic acid in determining the survival of glycoproteins in the circulation","volume":"246","author":"AG Morell","year":"1971","journal-title":"J Biol Chem"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jmb.2010.08.033","article-title":"Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity","volume":"403","author":"L Kong","year":"2010","journal-title":"J Mol Biol"},{"issue":"27","key":"ref29","doi-asserted-by":"crossref","first-page":"20860","DOI":"10.1074\/jbc.M109.085472","article-title":"Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition","volume":"285","author":"M Raska","year":"2010","journal-title":"J Biol Chem"},{"issue":"7427","key":"ref30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"F Klein","year":"2012","journal-title":"Nature"},{"issue":"7475","key":"ref31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"M Shingai","year":"2013","journal-title":"Nature"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.cell.2014.07.043","article-title":"Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice","volume":"158","author":"A Halper-Stromberg","year":"2014","journal-title":"Cell"},{"issue":"15","key":"ref33","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1073\/pnas.1620788114","article-title":"Effectiveness of UNAIDS targets and HIV vaccination across 127 countries","volume":"114","author":"J Medlock","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0042-6822(88)90568-5","article-title":"Envelope sequences of two new United States HIV-1 isolates","volume":"164","author":"C Gurgo","year":"1988","journal-title":"Virology"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1089\/aid.1992.8.1887","article-title":"Genetic variants of HIV-1 in Thailand","volume":"8","author":"FE McCutchan","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","article-title":"Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data","volume":"28","author":"M Kearse","journal-title":"Bioinformatics"},{"article-title":"Corning Incorporated Life Sciences Corning","year":"2001","author":"J Gibbs","key":"ref37"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nm0698-679","article-title":"A role for carbohydrates in immune evasion in AIDS","volume":"4","author":"JN Reitter","year":"1998","journal-title":"Nat Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nature01470","article-title":"Antibody neutralization and escape by HIV-1","volume":"422","author":"X Wei","year":"2003","journal-title":"Nature"},{"issue":"7525","key":"ref40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature13601","article-title":"Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface","volume":"515","author":"J Huang","year":"2014","journal-title":"Nature"},{"issue":"6165","key":"ref41","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1126\/science.1245625","article-title":"Crystal structure of a soluble cleaved HIV-1 envelope trimer","volume":"342","author":"JP Julien","year":"2013","journal-title":"Science"},{"issue":"5993","key":"ref42","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"X Wu","year":"2010","journal-title":"Science"},{"issue":"30","key":"ref43","doi-asserted-by":"crossref","first-page":"20526","DOI":"10.1074\/jbc.M114.554089","article-title":"HIV-1 envelope proteins and V1\/V2 domain scaffolds with mannose-5 to improve the magnitude and quality of protective antibody responses to HIV-1","volume":"289","author":"JF Morales","year":"2014","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12977-016-0241-5","article-title":"Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies","volume":"13","author":"SA Krumm","year":"2016","journal-title":"Retrovirology"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/JVI.01765-09","article-title":"Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites","volume":"84","author":"B Yu","year":"2010","journal-title":"J Virol"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/aid.1991.7.3","article-title":"The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?","volume":"7","author":"GJ Clements","year":"1991","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrmicro3360","article-title":"Novel vaccine vectors for HIV-1","volume":"12","author":"DH Barouch","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2016.05.011","article-title":"New concepts in HIV-1 vaccine development","volume":"41","author":"KE Stephenson","year":"2016","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nsmb.3144","article-title":"Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design","volume":"23","author":"J Gorman","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"6133","key":"ref50","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"J Jardine","year":"2013","journal-title":"Science"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"e1003106","DOI":"10.1371\/journal.ppat.1003106","article-title":"Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs","volume":"9","author":"S Hoot","year":"2013","journal-title":"PLoS Pathog"},{"issue":"5993","key":"ref52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1126\/science.1192819","article-title":"Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01","volume":"329","author":"T Zhou","year":"2010","journal-title":"Science"},{"issue":"8","key":"ref53","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1073\/pnas.91.8.3348","article-title":"Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody","volume":"91","author":"AJ Conley","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7424","key":"ref54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nature11544","article-title":"Broad and potent neutralization of HIV-1 by a gp41-specific human antibody","volume":"491","author":"J Huang","year":"2012","journal-title":"Nature"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.immuni.2004.12.011","article-title":"Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41","volume":"22","author":"RM Cardoso","year":"2005","journal-title":"Immunity"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.celrep.2014.04.001","article-title":"Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike","volume":"7","author":"L Scharf","year":"2014","journal-title":"Cell Rep"},{"key":"ref57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4235","article-title":"Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail","author":"B Julg","year":"2017"},{"issue":"7491","key":"ref58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"BE Correia","year":"2014","journal-title":"Nature"},{"issue":"7","key":"ref59","doi-asserted-by":"crossref","first-page":"e99881","DOI":"10.1371\/journal.pone.0099881","article-title":"Transplanting supersites of HIV-1 vulnerability","volume":"9","author":"T Zhou","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2016.01.007","article-title":"HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies","volume":"37","author":"SW de Taeye","year":"2016","journal-title":"Trends Immunol"},{"issue":"5561","key":"ref61","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1069540","article-title":"Mannose receptor-mediated regulation of serum glycoprotein homeostasis","volume":"295","author":"SJ Lee","year":"2002","journal-title":"Science"},{"issue":"5824","key":"ref62","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1137971","article-title":"Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation","volume":"316","author":"S Burgdorf","year":"2007","journal-title":"Science"},{"issue":"11","key":"ref63","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1371\/journal.ppat.0030169","article-title":"HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells","volume":"3","author":"M Shan","year":"2007","journal-title":"PLoS Pathog"},{"issue":"1","key":"ref64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2009.00801.x","article-title":"CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions","volume":"230","author":"L Nitschke","year":"2009","journal-title":"Immunol Rev"},{"issue":"21","key":"ref65","doi-asserted-by":"crossref","first-page":"11735","DOI":"10.1128\/JVI.01084-12","article-title":"Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin","volume":"86","author":"RP de Vries","year":"2012","journal-title":"J Virol"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/aid.2011.0101","article-title":"Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice","volume":"28","author":"K Banerjee","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref67","first-page":"7933","article-title":"Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1","author":"S Wang","journal-title":"J Virol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0196370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T21:56:26Z","timestamp":1661032586000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0196370"}},"subtitle":[],"editor":[{"given":"Aftab A.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,24]]},"references-count":67,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0196370","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,4,24]]}}}